Solesence (SLSN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Revenue for Q2 2025 grew 56% year-over-year to $20.4 million, driven by strong commercial execution, demand for consumer products, and new partnerships.
Net income rose to $2.7 million, including a $1.2 million Employee Retention Credit, up from $0.9 million in Q2 2024.
Successfully managed increased seasonal volume, with shipment and production volumes up 102% and 127% year-over-year, solidifying customer relationships.
Uplisted to NASDAQ and included in Russell 3000 and 2000 indices, enhancing visibility and marketability.
The company rebranded as Solésence, Inc. in March 2025.
Financial highlights
Q2 2025 revenue reached $20.4 million, a 56% increase year-over-year; product revenue was $20.3 million, with other revenue at $98,000.
Gross profit was $5.9 million, up from $3.7 million in Q2 2024; gross margin held steady at 29% year-over-year, improving 6 points sequentially.
EBITDA increased to $3.5 million from $1.4 million in the prior year, with adjusted EBITDA margin reflecting operational leverage and one-time credits.
Operating income for Q2 2025 was $1.9 million, up from $1.0 million in Q2 2024.
EPS was $0.04 basic and diluted, compared to $0.02 and $0.01 in Q2 2024.
Outlook and guidance
Management expects continued growth in consumer products, with capacity expansion, cost efficiency, and innovation as key focuses.
Anticipates moderating demand in the second half of 2025 due to seasonality, longer purchasing cycles, and tariff-related uncertainties.
Still projects a record revenue year despite expected headwinds.
Capital spending for 2025 is projected between $1 million and $3 million, funded by operations, loans, and possible new debt.
Expects further gross margin and EBITDA improvements as operational efficiencies and automation take effect.
Latest events from Solesence
- Record revenue, margin gains, and Nasdaq uplisting plans highlight robust growth outlook.SLSN
Q4 20243 Feb 2026 - Record Q2 revenue and profit, with Solésence driving 44% year-over-year growth.SLSN
Q2 20242 Feb 2026 - Record Q3 revenue, profit, and margin gains fueled by Solésence's exceptional growth.SLSN
Q3 202417 Jan 2026 - Director elections, auditor ratification, and governance updates headline the annual meeting.SLSN
Proxy Filing2 Dec 2025 - Annual meeting to elect directors, approve new equity plan, and ratify auditor, with Board support.SLSN
Proxy Filing2 Dec 2025 - Q1 revenue up 48% to $14.6M; margins fell on launch costs but recovery is expected.SLSN
Q1 202524 Nov 2025 - Q3 revenue dropped 14%, but strategic changes and strong brands support future growth.SLSN
Q3 202517 Nov 2025